Archived Clinical Summary
Chronic Obstructive Pulmonary Disease (COPD): Screening
Originally published on: January 10, 2014
This recommendation statement is currently archived and inactive. It should be used for historical purposes only. Click here for copyright and source information .
Disclaimer:Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Archived: Clinical Summary of U.S. Preventive Services Task Force Recommendation
This document is a summary of the 2008 recommendation of the U.S. Preventive Services Task Force (USPSTF) on screening for chronic obstructive pulmonary disease using spirometry. This summary is intended for use by primary care clinicians.
Select fo copyright and source information.
|Population||Adult General Population|
|Recommendation||Do not screen for chronic obstructive pulmonary disease using spirometry
|Additional Population Information||
|Other Approaches to the Prevention of Pulmonary Illnesses||
|Relevant USPSTF Recommendations||
1 The potential benefit of spirometry-based screening for COPD is prevention of one or more exacerbations by treating patients found to have an airflow obstruction previously undetected. However, even in groups with the greatest prevalence of airflow obstruction, hundreds of patients would need to be screened with spirometry to defer one exacerbation.
For a summary of the evidence systematically reviewed in making this recommendation, please go to the full supporting documents.
This document is in the public domain within the United States.
Requests for linking or to incorporate content in electronic resources should be sent via the USPSTF contact form.
Internet Citation: Clinical Summary: Chronic Obstructive Pulmonary Disease (COPD): Screening. U.S. Preventive Services Task Force. December 2014.